Motilent

Motilent is a technology company focused on medical imaging and collaborative solutions for gastroenterology. Founded by Alex Menys, PhD, the company aims to enhance the understanding and treatment of digestive diseases through advanced, non-invasive imaging technologies like MRI, ultrasound, and capsule endoscopy. Their work addresses various gastrointestinal conditions, including inflammatory bowel disease, constipation, and irritable bowel syndrome. The company’s flagship product, GIQuant, provides an objective disease activity score for small bowel conditions by analyzing MRI data. It is FDA cleared and CE marked, making it suitable for both adults and children. Motilent also offers Entrolytics, a secure platform for managing gastrointestinal imaging data, and various specialized tools for assessing motility and other GI parameters. Their technology supports clinical applications such as surgical planning and treatment response measurement, ultimately aiming to improve patient outcomes in digestive health.

• Employees 25
• Founded 2013
• Total Funding $860620